The power of PCR
in your hands

Results delivered at the point of care in under 30 minutes

The Only Instrument-Free,
Rapid PCR Test

Our rapid PCR tests provide accurate and reliable results for healthcare providers all across the United States. We are a medical diagnostics company with portable PCR testing technology that may be implemented in both clinical and mobile laboratory settings.

Visby Medical strives to make access to infectious disease testing as easy and as accessible as possible.

Visby Medical Respiratory Health Test
Visby Medical Sexual Health Test

PCR Results in
Less Than 30 Minutes

In a world where speed and accuracy in disease testing has become increasingly important, the efficient protection of public health depends on the delivery of fast and reliable infectious disease testing to affected communities as quickly as possible.

The Visby Medical portable, instrument-free PCR test delivers results in minutes, not days, making our PCR test kits a revolution in the molecular diagnostics industry.

The following are five key benefits to using Visby PCR in your lab or clinic, right at the point of care.

True PCR results in under 30 minutes

True PCR results in under 30 minutes

Portable, deployable, and scalable

Portable, deployable, and scalable

Accuracy of 97% or greater

PCR accuracy

No instrument, no maintenance

No instrument,
no maintenance

No capital investment, no service contracts

No capital investment, no service contracts

What is Visby PCR?

It’s a full 40-cycle PCR lab in an incredibly small package. It’s also fast, creating a whole new category at the intersection of accuracy, speed and deployability. That’s a powerful new force that delivers a new era in results-driven diagnosis and informed treatment, during the patient visit.

Medical Company
with a Human Focus

As a molecular diagnostics company, we recognize that there is always an anxious patient waiting. For that reason, we created highly accurate, easy-to-run, rapid PCR testing kits to help contain and control the spread of dangerous pathogens fast.

Our aim is to continue developing testing devices that are reliably accurate. The current lack of rapid PCR testing available to inform a timely and accurate diagnosis for the patient demonstrates the inherent need for the Visby Medical diagnostic platform.

PCR results to treat in the same visit. That’s a first!

Visby Medical reduced a ~6-day1 central lab wait time down to under 30 minutes at the point-of-care. You can walk into the exam room with the answer, patients walk out with confidence. Patient callbacks and loss to follow up may become a thing of the past.

1. STD Journal

PCR lab instrument down to the palm of your hand
5 feet
<5 inches

The biggest improvements are often the smallest.

Visby Medical shrank the traditional sofa-sized PCR lab-instrument down to the palm of your hand. Now it’s portable, and easily deployable, in a 5" by 2" device. Revolutionary.

Small and mighty fast.

Capable of identifying multiple pathogens from the same sample, the miniaturized Visby Medical PCR device delivers accuracy just like central lab instruments, only thousand times smaller and faster. That’s huge.

Opened bird cage
Bird flying free

Surge capacity, without capital investment or maintenance.

Is it instrument-free or is it cartridge-free? It’s both, because it’s all-in-one, single-use, and disposable. Add more tests as your testing demand increases. Scale back as patient demand subsides. Order today and begin testing as soon as tomorrow.2

2. Depending on shipping.


To the agencies and entities that supported us, we are proud to deliver the next generation of PCR diagnostics.

At Visby Medical, we humbly believe our new diagnostic platform will become the gold standard among PCR point-of-care devices, by delivering accurate results in under 30 minutes to empower clinicians with data-driven results, while with their patient.

BARDA logo

February 2, 2021: Visby receives a $12.3 million award from BARDA to speed development of its rapid, single-use Flu-COVID PCR Test.

Read more
NIH and Lancet logos

November 23, 2020: Visby Medical Sexual Health Test clinical study, sponsored by NIH/NIAID, is published in The Lancet: “Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.”

Read more
NIH logo

October 6, 2020: Visby receives $10 Million from the NIH as part of its Rapid Acceleration of Diagnostics (RADx) initiative.

Read more
NIH and BARDA logos

August 5, 2020: Visby Medical selected as the ONLY winner of $19 Million in the Antimicrobial Resistance (AMR) Diagnostic Challenge (co-sponsored by BARDA and the NIH).

Read more

Are you ready to bring the power of lab PCR to your point of care clinic?

How to Buy
Adam de la Zerda, PhD

I started Visby Medical to solve the problem that at any given moment, millions of people are waiting for a diagnosis—often waiting for days when it should be minutes. I set out to create a tiny diagnostic tool with the gold standard accuracy of PCR but, unlike big central lab instruments, could deliver results fast, in minutes, so the clinician can make a data-driven decision. I wanted to create a diagnostic tool which would be small and portable enough to work anywhere, with no separate instrumentation, and which would be simple enough to be used by anyone, anywhere, anytime.

Adam de la Zerda, PhD

Founder, CEO

Gary Schoolnik, MD

The beauty of the Visby Medical platform isn’t just the accuracy and size of the device, but also the speed which enables doctors to maximize their time with patients, during that key initial visit. So, rather than spending precious time guessing, Visby Medical enables clinicians to spend time having a real conversation with the patient, listening and making a real connection, with real impact on public health and clinicians too. As a professor at Stanford Medical school, this is the standard of care we all aspire to: the ability to treat the whole patient — not just the disease.

Gary Schoolnik, MD

Chief Medical Officer

Peter Löscher

Visby is important to the world and to business, not only because it has achieved unbelievable advances in PCR testing and diagnostics in general, but also because it is a purpose-driven company — and that is the future. Visby is among the first in a new era of purpose-driven companies helping to ensure free enterprise builds a better world.

Peter Löscher

Former president, Global Human Health at global pharmaceutical company Merck & Co

Sir Ronald Cohen

The COVID-19 pandemic has highlighted the vital importance of very accurate, quick-response, single-use tests. With them, lives can return to normal both in developed and developing countries without causing numerous casualties. Visby’s team has shown how brilliant entrepreneurship can bring groundbreaking innovation in testing, not just for COVID-19, but for all infectious diseases, now and in the future.

Sir Ronald Cohen

Preeminent international philanthropist, venture capitalist, private equity investor and social innovator

Dr. Rick Klausner

Visby has solved one of the most important problems in testing. Now the most extraordinary diagnostic technology, PCR, is simple and accessible. This is an enormous advancement in putting healthcare in the hands of people.

Dr. Rick Klausner

Founder and Executive Chairman of Lyell Immunopharma, Inc., and president of the Milky Way Research Foundation

Dr. Shlomo Melmed

PCR, when appropriately applied, generates a highly sensitive and precise result. Visby’s PCR technology is so sensitive that it will pick up a signal that is likely to otherwise be missed. They have miniaturized PCR, validating it in the most rigorous fashion that satisfies both the compliance agencies as well as practicing physicians. This is a very important patient-friendly advance, which will lead to a new class of point of care diagnostics.

Dr. Shlomo Melmed

Visby Medical Board Member, Executive Vice President of Academic Affairs, Dean of the Medical Faculty and Professor of Medicine at Cedars-Sinai

Visby Medical in the media

  • WAAY 31 TV


    WAAY 31 TV

    Madison County clinic offering new STD test with results in 30 minutes

  • KOLD News 13


    KOLD News 13

    Chiricahua Community Health Centers Launches STI Testing Program for Women with Same-Day Results

  • Yahoo! Finance


    Yahoo! Finance

    Visby Medical to develop rapid flu-COVID PCR test as U.S. cases top 27M

  • Bloomberg Quicktake


    Bloomberg Quicktake

    Visby Medical's Adam de la Zerda on Bloomberg Quicktake.

  • CBS



    Visby Medical CEO on developing a portable PCR test for Coronavirus.




    Visby Medical on AACC TV

  • CNBC Mad Money


    CNBC Mad Money

    Visby Medical CEO Adam de la Zerda discusses COVID-19 Test Production.

  • Reuters



    Visby Medical's COVID-19 test gets FDA EUA.